Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
Companies
» Company Monitoring Page for BioSante
Company Monitoring Page for BioSante
latest headlines for company on cafepharma
Faruqi & Faruqi, LLP Announces Investigation of BioSante Pharmaceuticals, Inc.
Bradenton Herald, FL
Sat, 02/11/12 - 12:54 pm
Tags:
BioSante
BioSante: LibiGel Lives On, FDA Word On Bio-T-Gel May Come At Any Time
Seeking Alpha
Fri, 02/10/12 - 10:50 am
Tags:
LibiGel
,
FDA
,
BioSante
,
Bio-T-Gel
,
female sexual dysfunction
,
Teva Pharmaceuticals
,
hypogonadism
3 Biotech Companies Down But Not Out
Seeking Alpha
Wed, 02/8/12 - 09:34 am
Tags:
Arena
,
Vivus
,
Orexigen
,
Biocryst
,
BioSante
6 Drug Stocks Unworthy of Biotech Bull Market
TheStreet.com
Tue, 02/7/12 - 10:49 am
Tags:
Cytori
,
Regeneron
,
Human Genome Sciences
,
Galena Biopharma
,
BioSante
,
EntreMed
What's Going on With These Biotech Stocks?
Motley Fool
Sat, 02/4/12 - 03:26 pm
Tags:
Cell Therapeutics
,
BioSante
,
Teva Pharmaceuticals
,
Aduro BioTech
,
Ariad Pharmaceuticals
,
Merck
2 Potentially Solid Transdermal Drug Biotechs With Catalysts For 2012
Seeking Alpha
Tue, 01/31/12 - 02:44 pm
Tags:
Abbott Laboratories
,
Apricus Biosciences
,
Warner Chilcott
,
BioSante
The Best Biotech Stocks Of 2012
Seeking Alpha
Mon, 01/23/12 - 02:19 pm
Tags:
Advanced Cell Technologies
,
Aeterna Zentaris
,
Antares
,
BioSante
,
Geron
,
Hikma
,
Keryx
,
Pfizer
,
Sanofi
,
Teva Pharmaceuticals
,
Transcept
,
Yakult Honsha
,
Watson Pharmaceuticals
3 Biotechs Hopefully To Get Rich Or Die Trying
Seeking Alpha
Wed, 01/4/12 - 09:28 am
Tags:
Advanced Cell Technologies
,
Aeterna Zentaris
,
BioSante
,
Dendreon
,
Keryx
[video]4 Biotechs Dominating the Week
Motley Fool
Mon, 12/19/11 - 04:06 pm
Tags:
YM BioSciences
,
BioSante
,
Pharmasset
,
Alexa
3 Biotechs That Were Crushed This Week And Why
Seeking Alpha
Sat, 12/17/11 - 11:36 am
Tags:
Antares
,
BioSante
,
Inhibitex
BioSante’s Female Desire Drug Fails to Boost Libido in Late-Stage Studies
Bloomberg
Wed, 12/14/11 - 06:41 pm
Tags:
BioSante
,
female sexual dysfunction
,
LibiGel
December Catalysts for Drug and Biotech Stocks
Minyanville
Sat, 12/3/11 - 11:11 am
Tags:
Pfizer
,
Aveo Pharmaceutical
,
Affymax
,
Amgen
,
Antares Pharma
,
Celgene
,
ONYX Pharmaceuticals
,
Seattle Genetics
,
Micromet
,
YM BioSciences
,
Regeneron
,
BioSante
[video] The Next Big Thing In Biotech: Biosante
TheStreet.com
Fri, 12/2/11 - 11:19 am
Tags:
BioSante
,
female sexual dysfunction
,
LibiGel
Every Biotech Is for Sale
Motley Fool
Wed, 11/30/11 - 10:45 am
Tags:
ONYX Pharmaceuticals
,
Achillion
,
BioSante
,
Indenix
,
Inhibitex
,
GSK
,
Bristol-Myers Squibb
,
Amarin
,
Exelixis
22 Hot Drugs Facing FDA Approval in 2012
TheStreet.com
Tue, 11/29/11 - 09:09 am
Tags:
Amarin
,
AMR101
,
Ironwood
,
linaclotide
,
Merck
,
Ariad
,
ridaforolimus
,
Vivus
,
Qnexa
,
Avanafil
,
Amgen
,
Xgeva
,
Cell Therapeutics
,
pixantrone
,
Kalydeco
,
Vertex
,
ONYX Pharmaceuticals
,
Carfilzomib
,
Pfizer
,
Bristol-Myers Squibb
,
Eliquis
,
Chelsea Therapeutics
,
Northera
,
Levadex
,
MAP Pharmaceuticals
,
Roche
,
Curis
,
vismodegib
,
Biogen Idec
,
Elan
,
Tysabri
,
Amylin
,
Bydureon
,
Dapagliflozin
,
Uplypso
,
Protalix BioTherapeutics
,
Teva Pharmaceuticals
,
BioSante
,
Bio-T-Gel
,
Corlux
,
Corcept Therapeutics
,
Discovery Labs
,
Surfaxin
Keeping An Eye On Both BioSante And Antares Pharma
Seeking Alpha
Wed, 11/16/11 - 05:24 pm
Tags:
BioSante
,
Antares
,
LibiGel
November Catalysts for Biotech and Drug Stocks
Minyanville
Mon, 10/31/11 - 11:34 am
Tags:
FDA
,
Regeneron
,
Vertex
,
Pharmasset
,
pSivida
,
Alimera
,
Salix
,
Teva Pharmaceuticals
,
BioSante
,
Transcept
BioSante Pharmaceuticals Closes $48.0 Million Public Offering of Common Stock
Benzinga
Sat, 10/29/11 - 02:42 pm
Tags:
BioSante
1 Biotech To Buy And 6 FDA Decision-Pending Biotechs To Avoid
Seeking Alpha
Fri, 10/28/11 - 11:07 am
Tags:
Celgene
,
Pacira
,
Incyte
,
BioSante
,
Regeneron
,
Transcept
,
Antares
7 FDA Decisions You Can't Afford to Ignore in Q4
Motley Fool
Sat, 10/15/11 - 11:39 am
Tags:
Bristol-Myers Squibb
,
Dapagliflozin
,
BioSante
,
Bio-T-Gel
,
Regeneron
,
Eylea
,
Transcept
,
Intermezzo
,
Incyte
,
ruxolitinib
,
Antares
,
Anturol
Pages
« first
‹ previous
1
2
3
4
5
next ›
last »
last 30 twitter posts
current feelings about your job
job rating
*
1 - I hate my job
2
3
4
5
6
7 - I love my job
Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
please tell us why
*
your industry
*
your job title (optional)
your company
*
published
N/A
published
not published
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
cafepharma is a: rock, tree, site
*
Fill in the blank.